Valence Medical Group operates at the intersection of international business, medical technology, and cross-border capital deployment. Our focus is not limited to individual ventures or assets, but on how business platforms are structured, integrated, and scaled to create sustainable long-term value.
Valence Medical Group is a medical device import and distribution company with international operations spanning Asia and the United States. Founded with roots in Singapore and active business presence in Los Angeles and New York, the company focuses on facilitating compliant cross-border trade of medical, aesthetic, and healthcare equipment. With hands-on experience across healthcare and beauty device supply chains, Valence Medical Group works closely with manufacturers, logistics partners, and regulatory bodies to ensure efficient sourcing, quality control, and market delivery. Our core business centers on product distribution, market access, and operational execution, supporting healthcare providers with reliable and compliant equipment solutions across global markets.
We work with institutional clients in the healthcare and regulated sectors to deliver end-to-end medical device trading solutions, supporting key decisions related to equipment renewal, product configuration, and long-term development. Our focus is on aligning medical device selection and supply solutions with each client’s operational needs, clinical use scenarios, and stage of development, ensuring that equipment deployment effectively supports both clinical outcomes and organizational objectives.Our approach emphasizes solution integrity, risk management, and long-term sustainability, assisting clients at critical stages of medical equipment upgrades and structural optimization, while avoiding configuration decisions driven by single-product considerations.
Our advisory approach emphasizes decision quality, risk awareness, and sustainable growth, prioritizing long-term value over short-term optimization.
Founder & Chief Executive Officer
Quinnie J. Clark is the Founder and Chief Executive Officer of Valence Medical Group, providing strategic leadership across healthcare innovation, cross-border clinical integration, and long-term institutional growth.
She brings a founder’s perspective shaped by international education and early exposure to global markets. Her academic experience at the National University of Singapore laid the groundwork for a disciplined approach to strategy, branding, and organizational development, which continues to influence her leadership philosophy and long-term vision for Valence Medical Group.
Under her direction, Valence Medical Group has expanded its international presence, strengthened governance frameworks, and positioned itself at the intersection of clinical excellence and sustainable healthcare investment.
Chief Operating Officer
Michael Harrison serves as Chief Operating Officer, overseeing the organization’s day-to-day operations and ensuring effective execution across key business functions. He is responsible for operational planning, process optimization, resource coordination, and cross-functional initiatives that support consistent organizational performance. With a strong focus on operational excellence and disciplined execution, Michael works closely with leadership, clinical, administrative, and support teams to streamline workflows, strengthen internal coordination, and ensure operations remain aligned with the company’s strategic priorities and evolving business requirements.
Chief Financial Officer
Catherine Mitchell serves as Chief Financial Officer, providing strategic leadership across the organization’s financial planning, reporting, and performance management functions. She oversees budgeting, forecasting, financial controls, capital allocation, and risk management while supporting the company’s long-term financial stability and growth objectives. With a strong emphasis on financial discipline, transparency, and data-driven decision-making, Catherine works closely with executive and operational teams to optimize resources, strengthen financial processes, and ensure financial priorities remain aligned with the organization’s broader strategic goals.
Cross-border trade in medical devices requires far more than capital investment alone. It depends on a deep understanding of regulatory pathways, accurate judgment of clinical application scenarios, and the ability to establish stable supply and distribution networks within highly regulated environments. Value is created through the systematic integration of product selection, channel execution, and long-term partnerships—rather than treating medical devices as simple tradable commodities. Sustainable growth is grounded in the effective alignment of medical technology, clinical demand, and institutional procurement systems, all of which are built upon long-term operational experience in the international medical device market.
Our professional focus is centered on four key pillars of medical innovation: intelligent auxiliary diagnostic products, intelligent auxiliary treatment products, intelligent monitoring and life support systems, and intelligent rehabilitation and physiotherapy solutions. By integrating these advanced systems with clinical data, we aim to build comprehensive platforms that enhance precision in diagnosis and treatment, ensuring continuous, high-quality care and operational scalability across global healthcare networks.
My path has been shaped by working across international business, healthcare, and investment, with a consistent focus on how platforms are built, integrated, and scaled globally. Experience operating in regulated industries revealed the limits of isolated ventures and underscored the importance of systems, execution, and long-term ownership. Over time, this perspective evolved into a disciplined approach to building sustainable enterprises where strategy, capital, and operations align to create durable value.
Building and scaling global platforms across healthcare and regulated industries, integrating capital strategy, operational execution, and long-term ownership across global markets.
Quinnie J. Clark received her education at the National University of Singapore, where she established a strong foundation in marketing and business management. Through advanced commercial training at the NUS Business School, she developed the strategic expertise and market acumen that continue to guide her work in scaling global platforms.
Design and leadership of strategic initiatives supporting healthcare-adjacent and commercial programs, integrating market insight, brand strategy, and cross-functional execution into scalable operating models.
Projects span market expansion, strategic partnerships, and organizational development, with a focus on long-term value creation, stakeholder alignment, and sustainable growth.
Recognized through participation in closed-door healthcare leadership forums and executive discussions focused on precision medicine, healthcare system design, and cross-border clinical integration.
Recognized through involvement in international advisory dialogues addressing cross-border market coordination, organizational structure, and strategic collaboration across healthcare and business ecosystems.
Recognized through engagement in healthcare philanthropy initiatives supporting health education, system capacity building, and long-term community impact across international contexts.
Dedicated to transforming scientific and clinical innovation into scalable healthcare systems through governance design, data integration, and incentive infrastructure.
Regularly invited to address international medical and life sciences conferences, healthcare innovation forums, and academic institutions, sharing insights on the future of integrated care.
Honored with multiple academic and professional accolades acknowledging contributions to translational research, clinical leadership, and strategic healthcare innovation.
Maintain active leadership roles within prominent international medical, scientific, and healthcare organizations, driving cross-border collaboration across Asia and Europe.
us@valencemedicalgroup.com
+1 646 271 7997
285 Fulton St
New York, NY 10007